Edward Littler
Profile
Edward Littler formerly worked at Domainex Ltd., as Chief Executive Officer & Director, Neuro-Bio Ltd., as Chairman, Medivir UK Ltd., as Senior Director-Lead Discovery, GSK Plc, as Head-Antiviral Research Unit, Translational Research Group, Inc., as Principal, Glaxo Wellcome, Inc., as Head-Antiviral Research, and Wellcome Research Laboratories, as Head-Herpes Virus Research.
Former positions of Edward Littler
| Companies | Position | End |
|---|---|---|
| GSK PLC | Corporate Officer/Principal | - |
Neuro-Bio Ltd.
 Neuro-Bio Ltd. BiotechnologyHealth Technology Neuro-Bio Ltd. operates as a biopharmaceutical company. It focuses on developing therapies for neurodegenerative disorders such as Alzheimer’s, Parkinson’s and Motor Neuron diseases. The company was founded by Susan Adele Greenfield in 2013 and is headquartered in Abingdon, the United Kingdom. | Chairman | - |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | - |
| Medivir UK Ltd. | Corporate Officer/Principal | - |
| Translational Research Group, Inc. | Corporate Officer/Principal | - |
Experiences
Positions held
Linked companies
| Listed companies | 1 |
|---|---|
| GSK PLC | Health Technology |
| Private companies | 6 |
|---|---|
| Translational Research Group, Inc. | |
| Glaxo Wellcome, Inc. | Health Technology |
Domainex Ltd.
 Domainex Ltd. Pharmaceuticals: MajorHealth Technology Domainex Ltd. operates as a drug discovery company. Its services include drug target expression, structural biology, virtual hit screening, medicinal chemistry, computational chemistry, assay development, and fragment based screening. The firm offers combinatorial domain hunting technology, and leadbuilder virtual hit screening software. The company was founded by Laurence Harris Pearl, Renos Savva, Paul Driscoll and Chrisostosmos Prodromou in 2001 and is headquartered in Saffron Walden, the United Kingdom. | Health Technology |
| Wellcome Research Laboratories | |
| Medivir UK Ltd. | |
Neuro-Bio Ltd.
Neuro-Bio Ltd. BiotechnologyHealth Technology Neuro-Bio Ltd. operates as a biopharmaceutical company. It focuses on developing therapies for neurodegenerative disorders such as Alzheimer’s, Parkinson’s and Motor Neuron diseases. The company was founded by Susan Adele Greenfield in 2013 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Edward Littler
